Team:Slovenia/ModelingDerivation
From 2012.igem.org
(6 intermediate revisions not shown) | |||
Line 2: | Line 2: | ||
<head> | <head> | ||
<meta http-equiv="X-UA-Compatible" content="IE=edge" /> | <meta http-equiv="X-UA-Compatible" content="IE=edge" /> | ||
+ | |||
+ | <!-- back to top --> | ||
+ | <div style="position:fixed; bottom:45px; right:30px; width:100px; height:66px; background-color:transparent;"> | ||
+ | <a href="#topofthepage"> | ||
+ | <table style="background-color:transparent;" onclick="window.location = '#topofthepage'" class="invisible" style="height:100%;"> | ||
+ | <tr class="invisible" style="background-color:transparent;"> | ||
+ | <td class="invisible" style="background-color:transparent;" valign="center"> | ||
+ | <img width="100px" src ="https://static.igem.org/mediawiki/2012/1/14/Svn12_hp_btt.png"></img> | ||
+ | </td></tr></table> | ||
+ | </a> | ||
+ | </div> | ||
+ | |||
+ | |||
<style type="text/css"> | <style type="text/css"> | ||
Line 13: | Line 26: | ||
- | p {line-height:1.5em; margin:0 0 15px; text-align: | + | p {line-height:1.5em; margin:0 0 15px; text-align:justify;} |
h2 {font-size:1.8em; font-weight:400; margin:0 0 12px;} | h2 {font-size:1.8em; font-weight:400; margin:0 0 12px;} | ||
Line 201: | Line 214: | ||
#cssmenu ul li > ul li{display:block; list-style:inside none; padding:0; margin:0; position:relative;} | #cssmenu ul li > ul li{display:block; list-style:inside none; padding:0; margin:0; position:relative;} | ||
#cssmenu ul li > ul li a{ outline:none; display:block; position:relative; margin:0; padding:8px 20px; font:10pt Arial, Helvetica, sans-serif; color:#fff; text-decoration:none; text-shadow:1px 1px 0 rgba(0,0,0, 0.5); } | #cssmenu ul li > ul li a{ outline:none; display:block; position:relative; margin:0; padding:8px 20px; font:10pt Arial, Helvetica, sans-serif; color:#fff; text-decoration:none; text-shadow:1px 1px 0 rgba(0,0,0, 0.5); } | ||
+ | #cssmenu ul li > ul li a table tr td span{ outline:none; display:block; position:relative; margin:0; padding:0px 0px; font:10pt Arial, Helvetica, sans-serif; color:#fff; text-decoration:none; text-shadow:1px 1px 0 rgba(0,0,0, 0.5); } | ||
#cssmenu, #cssmenu > ul > li > ul > li a:hover | #cssmenu, #cssmenu > ul > li > ul > li a:hover | ||
{ background:#043A6B; | { background:#043A6B; | ||
Line 216: | Line 230: | ||
#cssmenu > ul > li > a:hover{background:#0C5DA5;} | #cssmenu > ul > li > a:hover{background:#0C5DA5;} | ||
/* end CSS navigation menu (blue) */ | /* end CSS navigation menu (blue) */ | ||
+ | |||
+ | /*new table start*/ | ||
+ | table.newtable {background-color:transparent;} | ||
+ | td.newtable, th.newtable {background-color:transparent;} | ||
+ | thead.newtable{ } | ||
+ | tbody .newtable{} | ||
+ | /*new table*/ | ||
Line 292: | Line 313: | ||
<body> | <body> | ||
+ | <a name="topofthepage" style="background-color:transparent;"></a> | ||
+ | |||
+ | |||
<div id="banner"> | <div id="banner"> | ||
- | <a style="position:absolute; top:0px; left:490px;" href="https://2012.igem.org/Main_Page"><b> | + | <a style="position:absolute; top:0px; left:490px;" href="https://2012.igem.org/Main_Page"><b></b></a> |
</div> | </div> | ||
Line 317: | Line 341: | ||
<li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchDesignedTALregulators'><span>Designed TAL regulators</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchDesignedTALregulators'><span>Designed TAL regulators</span></a></li> | ||
<li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchMutualRepressorSwitch'><span>Mutual repressor switch</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchMutualRepressorSwitch'><span>Mutual repressor switch</span></a></li> | ||
- | <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchPositiveFeedbackLoopSwitch'><span>Positive feedback loop switch</span></a></li> | + | <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchPositiveFeedbackLoopSwitch'><table onclick="window.location = 'https://2012.igem.org/Team:Slovenia/TheSwitchPositiveFeedbackLoopSwitch';" class="newtable"><tr class="newtable"><td class="newtable"><span>Positive feedback loop switch</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> |
+ | <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchControls'><table onclick="window.location = 'https://2012.igem.org/Team:Slovenia/TheSwitchControls';" class="newtable"><tr class="newtable"><td class="newtable"><span>Controls</span></td><td class="newtable"><img style="margin-right:-81px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
Line 325: | Line 350: | ||
<li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsEscapeTag'><span>Escape tag</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsEscapeTag'><span>Escape tag</span></a></li> | ||
<li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsTermination'><span>Termination</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsTermination'><span>Termination</span></a></li> | ||
- | + | <li><a href="https://2012.igem.org/Team:Slovenia/SafetyMechanismsMicrocapsuleDegradation"><table onclick="window.location = 'https://2012.igem.org/Team:Slovenia/SafetyMechanismsMicrocapsuleDegradation';" class="newtable"><tr class="newtable"><td class="newtable"><span>Microcapsule degradation</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> | |
</ul> | </ul> | ||
</li> | </li> | ||
Line 333: | Line 358: | ||
<li><a href='https://2012.igem.org/Team:Slovenia/ImplementationHepatitisC'><span>Hepatitis C</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationHepatitisC'><span>Hepatitis C</span></a></li> | ||
<li><a href='https://2012.igem.org/Team:Slovenia/ImplementationIschaemicHeartDisease'><span>Ischaemic heart disease</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationIschaemicHeartDisease'><span>Ischaemic heart disease</span></a></li> | ||
+ | <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationImpact'><table onclick="window.location = 'https://2012.igem.org/Team:Slovenia/ImplementationImpact';" class="newtable"><tr class="newtable"><td class="newtable"><span>Impact</span></td><td class="newtable"><img style="margin-right:-86px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> | ||
</ul> | </ul> | ||
Line 340: | Line 366: | ||
<ul> | <ul> | ||
<li><a href='https://2012.igem.org/Team:Slovenia/Modeling'><span>Overview</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/Modeling'><span>Overview</span></a></li> | ||
- | + | <li><a href='https://2012.igem.org/Team:Slovenia/ModelingPK'><table onclick="window.location = 'https://2012.igem.org/Team:Slovenia/ModelingPK';" class="newtable"><tr class="newtable"><td class="newtable"><span>Pharmacokinetics</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> | |
<li><a href='https://2012.igem.org/Team:Slovenia/ModelingMethods'><span>Modeling methods</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/ModelingMethods'><span>Modeling methods</span></a></li> | ||
<li><a href='https://2012.igem.org/Team:Slovenia/ModelingMutualRepressorSwitch'><span>Mutual repressor switch</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/ModelingMutualRepressorSwitch'><span>Mutual repressor switch</span></a></li> | ||
<li><a href='https://2012.igem.org/Team:Slovenia/ModelingPositiveFeedbackLoopSwitch'><span>Positive feedback loop switch</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/ModelingPositiveFeedbackLoopSwitch'><span>Positive feedback loop switch</span></a></li> | ||
- | <li><a href='https://2012.igem.org/Team:Slovenia/ModelingQuantitativeModel'><span> | + | <li><a href='https://2012.igem.org/Team:Slovenia/ModelingQuantitativeModel'><table onclick="window.location = 'https://2012.igem.org/Team:Slovenia/ModelingQuantitativeModel';" class="newtable"><tr class="newtable"><td class="newtable"><span>Experimental model</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> |
- | + | <li><a href='https://2012.igem.org/Team:Slovenia/ModelingInteractiveSimulations'><table onclick="window.location = 'https://2012.igem.org/Team:Slovenia/ModelingInteractiveSimulations';" class="newtable"><tr class="newtable"><td class="newtable"><span>Interactive simulations</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> | |
</ul> | </ul> | ||
</li> | </li> | ||
Line 356: | Line 382: | ||
<ul> | <ul> | ||
<li><a href='https://2012.igem.org/Team:Slovenia/Notebook'><span>Experimental methods</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/Notebook'><span>Experimental methods</span></a></li> | ||
- | + | <li><a href='https://2012.igem.org/Team:Slovenia/NotebookLablog'><table onclick="window.location = 'https://2012.igem.org/Team:Slovenia/NotebookLablog';" class="newtable"><tr class="newtable"><td class="newtable"><span>Lablog</span></td><td class="newtable"><img style="margin-right:-90px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> | |
<li><a href='https://2012.igem.org/Team:Slovenia/NotebookLabSafety'><span>Lab safety</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/NotebookLabSafety'><span>Lab safety</span></a></li> | ||
</ul> | </ul> | ||
Line 379: | Line 405: | ||
<li><a href='https://2012.igem.org/Team:Slovenia/Team'><span>Team members</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/Team'><span>Team members</span></a></li> | ||
<li><a href='https://2012.igem.org/Team:Slovenia/TeamAttributions'><span>Attributions</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/TeamAttributions'><span>Attributions</span></a></li> | ||
+ | <li><a href='https://2012.igem.org/Team:Slovenia/TeamCollaborations'><table onclick="window.location = 'https://2012.igem.org/Team:Slovenia/TeamCollaborations';" class="newtable"><tr class="newtable"><td class="newtable"><span>Collaborations</span></td><td class="newtable"><img style="margin-right:-20px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> | ||
<li><a href='https://2012.igem.org/Team:Slovenia/TeamGallery'><span>Gallery</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/TeamGallery'><span>Gallery</span></a></li> | ||
<li><a href='https://2012.igem.org/Team:Slovenia/TeamSponsors'><span>Sponsors</span></a></li> | <li><a href='https://2012.igem.org/Team:Slovenia/TeamSponsors'><span>Sponsors</span></a></li> | ||
Line 391: | Line 418: | ||
<div id="main"> | <div id="main"> | ||
<br/> | <br/> | ||
+ | |||
+ | <!-- dummy link na bannerju --> | ||
+ | <a href="https://2012.igem.org/Main_Page"> | ||
+ | <div id="dummy" style="background-color:transparent; position:absolute; left:870px; top:25px; width:115px; height:80px; z-index:100; opacity:0.0;"> | ||
+ | </div> | ||
+ | </a> | ||
+ | |||
<h1>Deterministic model derivation - genetic switch</h1> | <h1>Deterministic model derivation - genetic switch</h1> | ||
<p> | <p> | ||
Line 404: | Line 438: | ||
<p>Construct 1 promoter state transitioning is described by a reaction:<img src="https://static.igem.org/mediawiki/2012/f/ff/Svn12_derivation1_eq1.png"/> | <p>Construct 1 promoter state transitioning is described by a reaction:<img src="https://static.igem.org/mediawiki/2012/f/ff/Svn12_derivation1_eq1.png"/> | ||
</p> | </p> | ||
- | + | <!-- | |
<p>Assuming equilibrium of binding and unbinding, we can write: | <p>Assuming equilibrium of binding and unbinding, we can write: | ||
<img src="https://static.igem.org/mediawiki/2012/f/f7/Svn12_derivation1_eq2.png"/> | <img src="https://static.igem.org/mediawiki/2012/f/f7/Svn12_derivation1_eq2.png"/> | ||
- | </p> | + | </p>--> |
<p> | <p> | ||
Line 419: | Line 453: | ||
<p> | <p> | ||
- | + | Assuming equilibrium of binding and unbinding, it follows that the fractional occupancy for construct 1 promoter is: | |
<img src="https://static.igem.org/mediawiki/2012/b/ba/Svn12_derivation1_eq4.png" /> | <img src="https://static.igem.org/mediawiki/2012/b/ba/Svn12_derivation1_eq4.png" /> | ||
</p> | </p> | ||
- | <p>To account for non-linearity, an exponent | + | <p>To account for non-linearity, an exponent n<sub>1</sub> was added, and the equation generalized to: |
<img src="https://static.igem.org/mediawiki/2012/a/a9/Svn12_derivation1_eq5.png" /> | <img src="https://static.igem.org/mediawiki/2012/a/a9/Svn12_derivation1_eq5.png" /> | ||
</p> | </p> | ||
Line 429: | Line 463: | ||
<p> | <p> | ||
- | K<sub>r</sub> is the amount of TAL-A:KRAB it takes for | + | K<sub>r</sub> is the amount of TAL-A:KRAB it takes for f<sub>1</sub> to be equal to 50% when n<sub>1</sub>=k<sub>1</sub>=1. |
</p> | </p> | ||
Line 449: | Line 483: | ||
The positive feedback loop switch model was derived in a similar manner. | The positive feedback loop switch model was derived in a similar manner. | ||
</p> | </p> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | <hr> | ||
+ | <b> | ||
+ | <a href='https://2012.igem.org/Team:Slovenia/ModelingMutualRepressorSwitch'>Deterministic model of the mutual repressor switch</a><br/> | ||
+ | <a href='https://2012.igem.org/Team:Slovenia/ModelingPositiveFeedbackLoopSwitch'>Deterministic model of the positive feedback loop switch</a> | ||
+ | |||
+ | </b> | ||
+ | |||
+ | |||
</div> | </div> |
Latest revision as of 18:02, 3 June 2013
Deterministic model derivation - genetic switch
The deterministic model for the mutual repressor switch was derived in the following way.
We assumed the following binding site states were possible:
Active promoter state is a state leading to gene expression.
Construct 1 promoter state transitioning is described by a reaction:
The fractional occupancy of construct 1 promoter, f1, can be expressed as a ratio of active states to all states:
The equations for other constructs take the same form.
Assuming equilibrium of binding and unbinding, it follows that the fractional occupancy for construct 1 promoter is:
To account for non-linearity, an exponent n1 was added, and the equation generalized to:
Kr is the amount of TAL-A:KRAB it takes for f1 to be equal to 50% when n1=k1=1.
Derivation for constructs 2, 3 and 4 was similar except for different transcription factor names.
Fractional occupancies were then used to construct a set of ordinary differential equations representing each protein production. Because each protein can be produced from different constructs, production rates (including leaky rates) were summed together. E.g., because TAL-B:KRAB is produced from both constructs 1 and 3, fractional occupancies f1 and f3 were used and corresponding terms summed to obtain:
Since construct 5 promoter has no binding sites and is active at all times, fractional occupancy of the promoter is equal to 1.
The positive feedback loop switch model was derived in a similar manner.
Deterministic model of the mutual repressor switch
Deterministic model of the positive feedback loop switch